 A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TWO-WAY CROSSOVER STUDY DESIGNED TO EVALUATE THE EFFICACY OF FEXOFENADINE HCL 180 MG FOR PREVENTING AND CONTROLLING CAT ALLERGY SYMPTOMS: 